Approval · Notice of Compliance 16430 · 2014
ACT FINASTERIDE: Notice of Compliance 16430
Issued December 11, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16430
- Date
- December 11, 2014
- Company
- Actavis Pharma CompanyToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Manufacturer and product name change
- Therapeutic class
- Type II 5 alpha-reductase inhibitor
- Canadian reference product
- PROSCAR (Merck Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACT FINASTERIDE | 02354462 | Cancelled Post Market |
Medicinal ingredients
- FINASTERIDE 5 MG per TAB